EARNINGS & TRADING: Microsalt lowers sales 2026 guidance
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 6.45p on 03-07-2026 at 16:55:11 |
|---|---|
| Change | 0.00p 0% |
| Buy | 6.50p |
| Sell | 6.40p |
| Last Trade: | Sell 7,797.00 at 6.40p |
| Day's Volume: | 148,077 |
| Last Close: | 6.45p |
| Open: | 6.45p |
| ISIN: | GB00BP0RTP38 |
| Day's Range | 6.45p - 6.45p |
| 52wk Range: | 4.60p - 13.25p |
| Market Capitalisation: | £6.66m |
| VWAP: | 6.400442p |
| Shares in Issue: | 103.30m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
OptiBiotix Health (OPTI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 7,797 | 6.40p | Ordinary |
13:47:30 - 03-Jul-26 |
| Buy* | 20 | 6.50p | SI Trade |
13:40:52 - 03-Jul-26 |
| Buy* | 239 | 6.50p | SI Trade |
13:40:52 - 03-Jul-26 |
| Sell* | 39,125 | 6.40p | Ordinary |
13:36:01 - 03-Jul-26 |
| Sell* | 38,000 | 6.40p | Ordinary |
09:05:27 - 03-Jul-26 |
| Sell* | 70,000 | 6.255p | Negotiated Trade |
16:03:36 - 02-Jul-26 |
| Buy* | 34 | 6.50p | Ordinary |
15:40:02 - 02-Jul-26 |
| Buy* | 34 | 6.50p | SI Trade |
15:40:02 - 02-Jul-26 |
| Buy* | 3,750 | 6.48p | Ordinary |
15:39:54 - 02-Jul-26 |
| Buy* | 2,769 | 6.50p | Ordinary |
15:23:22 - 02-Jul-26 |
OptiBiotix Health (OPTI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 26th Jun 2026 3:00 pm | RNS-R | Investor presentation and Q&A |
| 23rd Jun 2026 4:25 pm | RNS | Result of AGM |
| 2nd Jun 2026 7:00 am | RNS-R | Investor presentation and SweetBiotix® Sampling |
| 29th May 2026 7:00 am | RNS | Director/PDMR Shareholding |
| 28th May 2026 7:00 am | RNS | Final Results & Notice of AGM |
| 14th May 2026 7:00 am | RNS-R | SweetBiotix® Sampling |
| 5th May 2026 2:30 pm | RNS | Holding(s) in Company |
| 1st May 2026 12:00 pm | RNS | Partial Disposal of Shares in SkinBioTherapeutics |
| 1st Apr 2026 7:00 am | RNS | Trading Update |
| 24th Feb 2026 7:00 am | RNS | WellBiome® clinical trial on surgical outcomes |